Scenarios that move QGEN

Qiagen N.V. Common Shares

Scenarios that move QGEN: 3 analyses, 2 positive, 1 negative.

  1. · OPKO Health to sell BioReference assets to Labcorp for $722M — ▼ · impact -12 · confidence low · horizon quarters
  2. · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▲ · impact +15 · confidence low · horizon weeks
  3. · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▲ · impact +15 · confidence low · horizon quarters

All scenarios · Run a scenario · Pricing